RASAZILECT rasagiline mesilate 1 mg tablets, blister

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

rasagiline mesilate, Quantity: 1.56 mg

Доступна з:

Arrotex Pharmaceuticals Pty Ltd

Фармацевтична форма:

Tablet, uncoated

Склад:

Excipient Ingredients: purified talc; microcrystalline cellulose; maize starch; citric acid; silicon dioxide; pregelatinised maize starch; stearic acid

Адміністрація маршрут:

Oral

Одиниць в упаковці:

10, 30

Тип рецепту:

(S4) Prescription Only Medicine

Терапевтичні свідчення:

Rasagiline is indicated for the symptomatic treatment of idiopathic Parkinsons disease (PD) as monotherapy (without concomitant levodopa/decarboxylase inhibitor therapy) or as adjunct therapy (with concomitant levodopa/decarboxylase inhibitor therapy).

Огляд продуктів:

Visual Identification: White to off-white, round, flat bevelled tablets debossed with "C13" on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизація:

Registered

Дата Авторизація:

2018-01-23